A new multi-direction DWI sequence, the latest Swoop® system software, and the first advancement in Hyperfine’s Optive AI™ software, delivers clearer, higher-quality images for stroke diagnosis, ...

Hyperfine, Inc. HYPR has received FDA clearance for its updated software for the Swoop system. This development aligns with the company’s efforts to strengthen its foothold in the growing Magnetic ...

GUILFORD, Conn., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world’s first FDA-cleared portable MRI ...

Rafael O’Halloran, PhD, and Rob Fasciano, PhD, bring depth and breadth of experience in imaging and Medtech. Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has ...

Guilford-based Hyperfine announced Tuesday it had secured FDA approval of a software update for its portable MRI device that will boost its image quality and accuracy. With the new software, the ...

GUILFORD, Conn. - Hyperfine, Inc. (NASDAQ:HYPR) announced Wednesday that its Swoop portable MRI system has received regulatory approval from India’s Central Drugs Standard Control Organization (CDSCO) ...

Innovative approaches in MRI technology demonstrate the potential of portable ultra-low-field brain imaging to assist in improving brain health GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc.

Hyperfine Announces FDA Clearance of the First Optive AI™ Software Update with Advanced Diffusion Imaging Capability, Focused on Enhancing Stroke Detection with the Swoop® System A new multi-direction ...

Rafael O’Halloran, PhD, and Rob Fasciano, PhD, bring depth and breadth of experience in imaging and Medtech. Rob Fasciano, PhD, joined Hyperfine as Chief Regulatory and Quality Officer, bringing over ...